• KOL
    • Blood Pressure
    • Paul Kieran Whelton
    • Paul Kieran Whelton: Influence Statistics

      Paul Kieran Whelton

      Paul Kieran Whelton

      Show email address

      Departments of Epidemiology and Medicine, Tulane University Health Sciences Center, New Orleans, LA (P.K.W.). | Department of Epidemiology, School of Public Health and ...

      Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile

      Paul Kieran Whelton:Expert Impact

      Concepts for whichPaul Kieran Wheltonhas direct influence:Blood pressure,Cardiovascular disease,Renal disease,Metabolic syndrome,United states,Sodium intake,African americans,Dietary sodium.

      Paul Kieran Whelton:KOL impact

      Concepts related to the work of other authors for whichfor which Paul Kieran Whelton has influence:Blood pressure,Metabolic syndrome,Cardiovascular disease,Heart failure,Hypertensive patients,Diabetes mellitus,Physical activity.

      KOL Resume for Paul Kieran Whelton

      Year
      2022

      Departments of Epidemiology and Medicine, Tulane University Health Sciences Center, New Orleans, LA (P.K.W.).

      Department of Epidemiology, School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA, USA

      Departamento de Epidemiología, Escuela de Salud Pública y Medicina Tropical de la Universidad de Tulane, Nueva Orleans, Estados Unidos de América, Departamento de Epidemiología, Escuela de Salud Pública y Medicina Tropical de la Universidad de Tulane, Nueva Orleans, Estados Unidos de América., Orcid:, https://orcid.org/0000-0002-2225-383X

      2021

      World Hypertension League, US

      Department of Medicine, Tulane University School of Medicine, New Orleans, LA

      Departamento de Epidemiologia e Medicina, Centro de Ciências da Saúde da Universidade de Tulane Nova Orleans Estados Unidos Departamento de Epidemiologia e Medicina, Centro de Ciências da Saúde da Universidade de Tulane, Nova Orleans, Estados Unidos.

      2020

      Tulane Univ, New Orleans, LA

      2019

      Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine

      Tulane University, New Orleans, Louisiana (P.K.W.).

      2018

      From the Department of Neurology, Medical University of South Carolina, Charleston (D.T.L.); Department of Medicine, University of Virginia Health System, Charlottesville (R.M.C.); Department of Neurology, Instituto Israelita de Ensino e Pesquisa, Hospital Israelita Albert Einstein, Sao Paulo, Brazil (A.B.C.); Department of Medicine (Cardiology), Mount Sinai Heart and the Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY (C.R.); James J. Peters VA Medical Center, Bronx, NY (C.R.); Department of Epidemiology, School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA (P.K.W.); and Division of Translational Science & Molecular Medicine, Michigan State University College of Human Medicine and Mercy Health Hauenstein Neurosciences, Grand Rapids (P.B.G.).

      School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA, USA

      Department of Epidemiology, Tulane University, New Orleans, LA.

      American Society for Preventive Cardiology Representative. †ACC/AHA Representative. ‡Lay Volunteer/Patient Representative. §Preventive Cardiovascular Nurses Association Representative. ‖American Academy of Physician Assistants Representative. ¶Task Force Liaison. #Association of Black Cardiologists Representative. **American Pharmacists Association Representative. ††ACC/AHA Prevention Subcommittee Liaison. ‡‡American College of Preventive Medicine Representative. §§American Society of Hypertension Representative. ‖‖Task Force on Performance Measures Liaison. ¶¶American Geriatrics Society Representative. ##National Medical Association Representative.

      2017

      Department of Epidemiology, Tulane School of Public Health and Tropical Medicine, New Orleans, Louisiana

      2016

      From the Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine (P.K.W., K.C.F.), and Department of Medicine, Tulane University School of Medicine (P.K.W., K.C.F.), New Orleans, LA; Division of Cardiovascular Sciences (P.T.E., P.D.-N., G.A.M., J.A.C.), and Center for Translation Research and Implementation Science (N.G., G.A.M.), National Heart, Lung, and Blood Institute, Bethesda, MD; Department of Epidemiology, School of Public Health, University of Alabama at Birmingham (P.M.); Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, MD (L.J.A., L.A.C., E.R.M.); Preventive Medicine Section, Veterans Affairs Medical Center, Memphis, TN (W.C.C.); Department of Epidemiology and Biostatistics, Dornsife School of Public Health, Drexel University, Philadelphia, PA (A.V.D.R.); Department of Medicine, Case Western Reserve University, University Hospitals Case Medical Center, Louis Stokes Cleveland VA Medical Center, OH (M.R., J.T.W.); Cardiovascular Research Institute, Morehouse School of Medicine, Atlanta, GA (H.A.T.); Department of Epidemiology and Prevention (J.A.) and Department of Medicine (B.I.F., J.A.), Wake Forest School of Medicine, Wake Forest University, Winston Salem, NC; Dean's Office, University of Kentucky College of Public Health, Lexington (D.K.A.); Department of Pharmacy Practice and Science, College of Pharmacy, University of Iowa, Iowa City (B.L.C.); Department of Biostatistics, University of Texas School of Public Health, Houston (B.R.D.); Department of Public Health Sciences, Stritch School of Medicine, Loyola University Chicago, Maywood, IL (R.C.); Division of Research, Kaiser Permanente Northern California, Oakland (A.S.G.); Department of Internal Medicine, Baylor College of Medicine, Houston, TX (D.J.H.); National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD (P.L.K.); HealthPartners Institute, Minneapolis, MN (K.L.M.); Duke Clinical Research Institute, Duke University Medical Center, Durham, NC (A.M.N.); Department of Population Health, NYU School of Medicine, New York (G.O.); American Medical Association, Chicago, IL (M.K.R.); Department of Nephrology and Hypertension, Cleveland Clinic, OH (G.T.); Clinical Directors Network (CND) and The Rockefeller University Center for Clinical and Translational Science, New York (J.N.T.); and National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, MD (S.S.(S.)Y.).

      Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA

      2015

      Tulane University School of Public Health and Tropical Medicine Department of Epidemiology New Orleans LA

      2014

      Department of Medicine (MK-W) Tulane University School of Medicine, New Orleans, Louisiana; Department of Epidemiology (MK-W, PKW), Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana; The Center for Health Research (MK-W) Research Division, Ochsner Clinic Foundation, New Orleans, Louisiana and Harvard Graduate School of Education (RK, LLL), Cambridge, Massachusetts.

      Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana, United States of America

      2013

      From the Vascular Biology and Hypertension Program, University of Alabama at Birmingham, Birmingham, AL (S.O.); Coordinating Center for Clinical Trials, Biostatistics Division, The University of Texas School of Public Health, Houston, TX (B.R.D., C.E.F.); Preventive Medicine Section, Memphis Veterans Affairs Medical Center, Memphis, TN (W.C.C.); Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC (C.D.F.); Veterans Affairs Medical Center Houston, Houston, TX (G.B.H); Keck School of Medicine, University of Southern California, Los Angeles, CA (L.J.H); Clinical Research, HealthPartners Institute for Education and Research, Minneapolis, MN (K.L.M); Clinical Trials Service Unit, University of Washington Medical Center Seattle, WA (J.L.P); Global Public Health, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA (P.K.W); and Division of Nephrology and Hypertension, University Hospitals Case Medical Center, Cleveland, OH (J.T.W.).

      2012

      Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana, United States of America

      Tulane University School of Medicine, New Orleans, LA, USA

      Due to the number of contributing authors, the affiliations are provided in the Supplemental Material

      From the Kaiser Permanente of Georgia and Emory University School of Medicine, Atlanta, GA (J.I.B.); The University of Texas School of Public Health, Houston, TX (S.L.P., B.R.D., C.E.F., L.B.P.); The National Heart, Lung, and Blood Institute, Bethesda, MD (J.A.C., P.T.E.); New York University Langone Medical Center, New York, NY (H.R.B.); Memphis Veterans Affairs Medical Center, Memphis, TN (W.C.C.); HealthPartners Research Foundation, Minneapolis, MN (K.L.M.); University of Colorado School of Medicine, Aurora, CO (J.M.); University of Alabama at Birmingham, Birmingham, AL (S.O.); University of Arkansas for Medical Sciences, Little Rock, AR (D.L.S.); Loyola University Medical Center, Maywood, IL (P.K.W.); University of California, Irvine, Irvine, CA (N.D.W.); University Hospitals of Cleveland, Cleveland, OH (J.T.W.); and Veterans Affairs Medical Center, Decatur, GA (M.E.S). A list of the ALLHAT Collaborative Research Group members has been published previously in JAMA . 2002;288:2981–2997.

      Sign-in to see all concepts, it's free!
      Sample of concepts for which Paul Kieran Whelton is among the top experts in the world.
      Concept World rank
      control egypt #1
      progressive fashion #1
      participants thiazide diuretic #1
      10 increase prevalence #1
      esrd africanamerican #1
      panel discussion hypertension #1
      wm diastolic #1
      repercussões #1
      impact antihypertensive medications #1
      treatment coffee consumption #1
      base incidence #1
      africanamerican esrd #1
      nsaids analgesic drug #1
      blood pressure jm #1
      pressure continental #1
      analgesics kidney #1
      control health organization #1
      health effects sodium #1
      acei lower risk #1
      hg criteria #1
      lisinopril initial treatment #1
      african americans baseline #1
      findingsdose #1
      esrd chronic male #1
      weight sensitivity heterogeneity #1
      esrd cumulative dose #1
      hypertension north america #1
      hypertension illness delivery #1
      channel blockers life #1
      89 mm hg #1
      hypertensive participants chlorthalidone #1
      order hypertension league #1
      dm lisinopril #1
      trends antihypertensive drug #1
      lower income africanamerican #1
      treatment type chlorthalidone #1
      stroke peoples republic #1
      whites ethnic difference #1
      excessive dietary sodium #1
      year diastolic pressure #1
      mm hg intervention #1
      ace levels blacks #1
      rhuepo diffusion costs #1
      110–165 #1
      prevention detection #1
      332544 #1
      blood pressure china #1
      elevations diastolic pressure #1
      chronically anephric subjects #1
      overweight adults trials #1
      Sign-in to see all concepts, it's free!

      Prominent publications by Paul Kieran Whelton

      KOL-Index: 19023

      BACKGROUND: This study was performed to determine whether, in high-risk hypertensive patients with a reduced glomerular filtration rate (GFR), treatment with a calcium channel blocker or an angiotensin-converting enzyme inhibitor lowers the incidence of renal disease outcomes compared with treatment with a diuretic.

      METHODS: We conducted post hoc analyses of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Hypertensive participants 55 years or ...

      Known for Renal Outcomes | Hypertensive Patients | Calcium Channel Blocker | Converting Enzyme | Amlodipine Lisinopril
      KOL-Index: 17350

      BACKGROUND: High blood pressure is an important public health concern because it is highly prevalent and a risk factor for adverse health outcomes, including coronary heart disease, stroke, decompensated heart failure, chronic kidney disease, and decline in cognitive function. Observational studies show a progressive increase in risk associated with blood pressure above 115/75 mm Hg. Prior research has shown that reducing elevated systolic blood pressure lowers the risk of subsequent ...

      Known for Blood Pressure | Intervention Trial | Chronic Kidney Disease | Cognitive Function | Heart Failure
      KOL-Index: 17211

      BACKGROUND: Guidelines, including the 2017 American College of Cardiology and American Heart Association blood pressure guideline, recommend tighter control of systolic blood pressure in people with type 2 diabetes. However, it is unclear whether intensive lowering of systolic blood pressure increases the incidence of chronic kidney disease in this population. We aimed to compare the effects of intensive systolic blood pressure control on incident chronic kidney disease in people with ...

      Known for Blood Pressure | Chronic Kidney Disease | Intensive Systolic | Diabetes Mellitus | Accord Trial
      KOL-Index: 16777

      CONTEXT: Few cardiovascular outcome data are available for blacks with hypertension treated with angiotensin-converting enzyme (ACE) inhibitors or calcium channel blockers (CCBs).

      OBJECTIVE: To determine whether an ACE inhibitor or CCB is superior to a thiazide-type diuretic in reducing cardiovascular disease (CVD) incidence in racial subgroups.

      DESIGN, SETTING, AND PARTICIPANTS: Prespecified subgroup analysis of ALLHAT, a randomized, double-blind, active-controlled, clinical outcome ...

      Known for Lisinopril Chlorthalidone | Hypertensive Black | 95 Hf | Ace Inhibitor | Calcium Channel Blockers
      KOL-Index: 16121

      IMPORTANCE: The appropriate treatment target for systolic blood pressure (SBP) in older patients with hypertension remains uncertain.

      OBJECTIVE: To evaluate the effects of intensive (<120 mm Hg) compared with standard (<140 mm Hg) SBP targets in persons aged 75 years or older with hypertension but without diabetes.

      DESIGN, SETTING, AND PARTICIPANTS: A multicenter, randomized clinical trial of patients aged 75 years or older who participated in the Systolic Blood Pressure Intervention ...

      Known for Standard Blood | Randomized Clinical Trial | Intensive Treatment | Sbp Target | Mm Hg
      KOL-Index: 15603

      Aims/hypothesisTo estimate the prevalence of diagnosed and undiagnosed diabetes and impaired fasting glucose in the general adult population of China.MethodsThe International Collaborative Study of Cardiovascular Disease in ASIA, conducted from 2000 to 2001, included a nationally representative sample of 15 540 adults, aged 35 to 74 years. An overnight fasting blood specimen was collected to measure serum glucose and information on history of diabetes and use of hypoglycaemic medications ...

      Known for Fasting Glucose | Cardiovascular Disease | China Diabetes | Chinese Adult | Collaborative Study
      KOL-Index: 15187

      Background Intensive systolic blood pressure ( SBP ) lowering significantly reduced cardiovascular disease ( CVD ) events in SPRINT (Systolic Blood Pressure Intervention Trial) but not in ACCORD BP (Action to Control Cardiovascular Risk in Diabetes Blood Pressure). Methods and Results SPRINT tested the effects of intensive (<120 mm Hg) versus standard (<140 mm Hg) SBP goals on CVD events and all-cause mortality. Using 2×2 factorial design, ACCORD BP tested the same SBP intervention in ...

      Known for Diabetes Mellitus | Cardiovascular Events | Blood Pressure | Accord Sprint | Type 2
      KOL-Index: 14960

      BACKGROUND: Variability of blood pressure (BP) across outpatient visits is frequently dismissed as random fluctuation around a patient's underlying BP.

      OBJECTIVE: To examine the association of visit-to-visit variability (VVV) of systolic BP (SBP) and diastolic BP with cardiovascular disease (CVD) and mortality outcomes.

      DESIGN: Prospective cohort study.

      SETTING: Post hoc analysis of ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).

      PARTICIPANTS: 25 814 ...

      Known for Heart Failure | Blood Pressure | Vvv Sbp | Visit Variability | Cvd Events
      KOL-Index: 14825

      OBJECTIVE: To compare the prevalence, awareness, treatment and control of hypertension in north and south, and urban and rural residents of China.

      DESIGN: A cross-sectional survey conducted in 2000-2001.

      SETTING AND PARTICIPANTS: A multistage cluster sampling method was used to select a nationally representative sample of 15 540 men and women aged 35-74 years from the general Chinese population.

      MAIN OUTCOME MEASURES: Three blood pressure measurements were obtained by trained observers ...

      Known for Hypertension China | Prevalence Awareness | Treatment Control | Blood Pressure | Antihypertensive Medications
      KOL-Index: 14785

      CONTEXT: Nonpharmacologic interventions are frequently recommended for treatment of hypertension in the elderly, but there is a paucity of evidence from randomized controlled trials in support of this recommendation.

      OBJECTIVE: To determine whether weight loss or reduced sodium intake is effective in the treatment of older persons with hypertension.

      DESIGN: Randomized controlled trial.

      PARTICIPANTS: A total of 975 [corrected] men and women aged 60 to 80 years with systolic blood pressure ...

      Known for Weight Loss | Nonpharmacologic Interventions | Randomized Controlled Trial | Treatment Hypertension | Reduced Sodium Intake
      KOL-Index: 14646

      Importance: Clinical trials have documented that lowering blood pressure reduces cardiovascular disease and premature deaths. However, the optimal target for reduction of systolic blood pressure (SBP) is uncertain.

      Objective: To assess the association of mean achieved SBP levels with the risk of cardiovascular disease and all-cause mortality in adults with hypertension treated with antihypertensive therapy.

      Data Sources: MEDLINE and EMBASE were searched from inception to December 15, ...

      Known for Cardiovascular Disease | Achieved Sbp | Blood Pressure | Network Meta | Mm Hg
      KOL-Index: 14271

      BACKGROUND: The 2017 American College of Cardiology/American Heart Association (ACC/AHA) Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults provides recommendations for the definition of hypertension, systolic and diastolic blood pressure (BP) thresholds for initiation of antihypertensive medication, and BP target goals.

      OBJECTIVES: This study sought to determine the prevalence of hypertension, implications of recommendations for ...

      Known for Blood Pressure | Antihypertensive Medication | 2017 Acc | Adults Hypertension | Aha Guideline
      KOL-Index: 14164

      Serum creatinine and endogenous creatinine clearance (CrCl) are widely used measures of renal function. This study compares the precision, bias, and sources of error in using different CrCl measures to estimate the glomerular filtration rate (GFR) in 118 men and women screened for the African-American Study of Kidney Disease and Hypertension (AASK) pilot study. We measured serum creatinine, 24-hour CrCl, and CrCl during timed clearance periods conducted simultaneously with an ...

      Known for Kidney Disease | Creatinine Clearance | Crcl Gfr | Renal Function | 24 Hour

      Key People For Blood Pressure

      Top KOLs in the world
      #1
      Giuseppe Mancia
      blood pressure heart rate metabolic syndrome
      #2
      Suzanne Oparil
      blood pressure resistant hypertension cardiovascular disease
      #3
      Gianfranco Gianfranco
      blood pressure heart failure european society
      #4
      Alberto Zanchetti
      blood pressure hypertensive patients essential hypertension
      #5
      Jackson T Wright
      blood pressure african americans kidney disease
      #6
      Jan Albert Staessen
      blood pressure systolic hypertension renal denervation

      Departments of Epidemiology and Medicine, Tulane University Health Sciences Center, New Orleans, LA (P.K.W.). | Department of Epidemiology, School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA, USA | Departamento de Epide

    Download on the App StoreGet it on Google Play

    Copyright © 2023 Key Opinion Leaders, LLC.